ArticleslgStudy

science

Vildagliptin/metformin

Vildagliptin/metformin is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Vildagliptin/metformin rather than just read about it. In short: Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type 2 diabetes. It was approved for use in the European Union in November 2007, and the approval was updated in 2008.

Key takeaways

  • Vildagliptin/metformin belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Vildagliptin/metformin to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Vildagliptin/metformin from memory before moving on to harder problems.

Reference excerpt

Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type 2 diabetes. It was approved for use in the European Union in November 2007, and the approval was updated in 2008. It combines 50 mg vildagliptin with either 500, 850, or 1000 mg metformin. The most common side effects include nausea (feeling sick), vomiting, diarrhea, abdominal (tummy) pain and loss of appetite.

Medical uses Vildagliptin/metformin is indicated in the treatment of type-2 diabetes mellitus:

it is indicated in the treatment of adults who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets. it is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea. it is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

References

External links "Vildagliptin". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 8 June 2020. "Metformin". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 17 May 2016.

Worked examples

Example 1 — a first encounter with Vildagliptin/metformin

Start with the simplest possible case. Write down what Vildagliptin/metformin claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Vildagliptin/metformin before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Vildagliptin/metformin ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Vildagliptin/metformin

In research
Vildagliptin/metformin appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Vildagliptin/metformin in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Vildagliptin/metformin is common in secondary-school and first-year university syllabi. It links to neighbouring topics Adamantanes, Biguanides, Carboxamides, so understanding it makes those chapters shorter.
In everyday life
Look for Vildagliptin/metformin outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Vildagliptin/metformin” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Vildagliptin/metformin in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Vildagliptin/metformin means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Vildagliptin/metformin out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Vildagliptin/metformin in simple terms?

Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type 2 diabetes. It was approved for use in the European Union in November 2007, and the approval was updated in 2008.

Why does Vildagliptin/metformin matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Vildagliptin/metformin?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Vildagliptin/metformin.

Tags

  • Adamantanes
  • Biguanides
  • Carboxamides
  • Combination diabetes drugs
  • Dipeptidyl peptidase-4 inhibitors
  • Drugs developed by Novartis
  • Drugs with unknown mechanisms of action
  • Guanidines
  • Nitriles
  • Pyrrolidines
  • Tertiary alcohols

Keep exploring